Trial Profile
Effect of Berberine on Cardiovascular Disease Risk Factors: a Mechanistic Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Berberine (Primary)
- Indications Cardiovascular disorders; Hyperlipidaemia
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 02 Nov 2020 Status changed from recruiting to completed.
- 24 Apr 2019 Status changed from not yet recruiting to recruiting.
- 17 Dec 2018 New trial record